Rocketvax and researchers at the University of Basel have linked up to develop a new approach for a COVID-19 vaccine.
Researchers led by Professor Thomas Klimkait at the University of Basel, in collaboration with Rocketvax, are now showcasing a vaccine concept that may lead to a new generation of vaccines against COVID-19.
The therapy involves a modified coronavirus that enters the body’s cells, activating an effective immune response, without multiplying in the body. Across animal studies, the vaccine effectively protected against the disease, while also preventing virus transmission…
